Eyenovia is a New York-based pharmaceutical company that specializes in developing innovative ophthalmic drug delivery technologies. Their cutting-edge Optejet dispenser delivers minimal amounts of medication to the eye, offering a safer and more effective alternative to traditional eyedroppers. With a focus on transformative therapies for progressive myopia, presbyopia, and mydriasis, Eyenovia aims to revolutionize the way eye medications are viewed by both eyecare professionals and patients. Through their commitment to reducing systemic exposure and toxicity, Eyenovia's microdosing technology has the potential to provide better tolerability and safety profiles compared to existing topical treatments. The company's Optejet dispenser, equipped with Bluetooth capability for improved patient compliance tracking, has the potential to be utilized for various applications and drug therapies. While not yet approved by the FDA or commercially available, Eyenovia's innovative approach to ophthalmic drug delivery holds great promise for the future of eye care.Generated from the website

A H Brown Interprise

Medical Education

Cac Group

Benjamin Berkowitz Autonomy Americas